SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as investors debate the impact of a massive share authorization and potential acquisition strategies involving eBay, while community sentiment remains sharply divided between those bracing for further dilution and those anticipating a major short squeeze. The conversation is further fueled by high-stakes speculation surrounding upcoming shareholder meetings and lingering frustration over the lack of concrete strategic guidance from leadership.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing high volatility as investors weigh a recent beat on delivery estimates and raised full-year production guidance against a fresh, dilutive public offering of 75 million shares. While some community members view the capital raise as a strategic move to secure DOE loan funding for facility expansion, many investors are expressing frustration over the dilution, leading to a sharp, polarized debate between those focusing on long-term growth and those fearing further downward pressure on the stock.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is seeing heightened activity as the community debates whether recent competitive headlines and sector volatility signal a structural threat or a temporary accumulation opportunity. Traders remain fixated on the stock's ability to reclaim the $200 level, with many viewing the ongoing price consolidation as a test of conviction amidst the broader AI infrastructure arms race.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending following a massive 20-year, 401-megawatt lease agreement with Anthropic for its Kentucky data center campus, which management describes as only the beginning of a broader AI infrastructure push. The community is intensely debating the deal's long-term revenue potential versus ongoing stock price volatility, with many users focused on whether the announcement justifies a significant valuation re-rating or if the sector remains hindered by broader market manipulation and short-term profit-taking.

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the development of imdusiran (AB-729), proprietary, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic, and AB-101, proprietary oral PD-L1 inhibitor, for the treatment of chronic hepatitis B (cHBV). The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Arbutus Biopharma Corp

Arbutus Biopharma is trending as investors digest the recent FDA Fast Track designation for its lead hepatitis B candidate, while community members remain hyper-focused on the potential for massive settlements with big pharmaceutical companies and a long-awaited breakout above a stagnant trading range. The discourse is dominated by frustration over alleged market manipulation and management's perceived lack of transparency, balanced against high expectations for institutional accumulation and a potential multi-billion dollar windfall from ongoing patent litigation.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending as market anticipation builds for the release of Phase 3 durability data, which is widely considered the final hurdle before the company's New Drug Application submission. The community is heavily focused on the stock's potential as a first-mover in the treatment-resistant depression space, with bullish sentiment bolstered by recent board expansions and ongoing federal interest in accelerating psychedelic therapy approvals.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as investors react to a significant clinical data milestone regarding the stabilization of kidney function for its lead drug, Atacicept, alongside optimism surrounding its regulatory pathway. The community is actively debating the stock's potential for a short squeeze due to high short interest, while institutional investors closely monitor its competitive positioning in the IgA nephropathy market.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is currently experiencing extreme volatility as investors navigate aggressive sector rotation and conflicting narratives regarding the sustainability of the AI semiconductor boom. Market participants remain sharply divided, with community discussions heavily split between 'dip buyers' betting on a rapid recovery and 'bears' highlighting the risks of high valuation and leveraged decay.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a strategic manufacturing alliance with Toyota, which aims to scale production for its S4 series electric air taxi. The community remains heavily divided between long-term bulls highlighting FAA certification progress and partnerships, and vocal short-sellers betting against cash burn and potential dilution.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as investors react to a solid earnings report and raised revenue guidance, fueling community speculation about a potential buyout or major partnership as the company approaches self-sustainability. Discussions remain heavily focused on the blockbuster potential of Recorlev and the upcoming Phase 3 development of their once-weekly injectable levothyroxine candidate, XP-8121.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PEOPLES BANCORP INC. TO ANNOUNCE 2ND QUARTER 2026 EARNINGS AND CONDUCT CONFERENCE CALL ON JULY 21, 2026

PEOPLES BANCORP INC. TO ANNOUNCE 2ND QUARTER 2026 EARNINGS AND CONDUCT CONFERENCE CALL ON JULY 21, 2026 PEOPLES BANCORP INC. TO ANNOUNCE 2ND QUARTER 2026 EARNINGS AND CONDUCT CONFERENCE CALL ON JULY 21, 2026 PR Newswire MARIETTA, Ohio, June 29, 2026 MARIETTA, Ohio, June 29, 2026 /PRNewswire...

What Makes Peoples Bancorp (PEBO) a New Buy Stock

Peoples Bancorp (PEBO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

James Abernethy Sells 600 Shares of Peoples Bancorp of North Carolina (NASDAQ:PEBK) Stock

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 600 shares of the firm's stock in a transaction that occurred on Thursday, April 30th. The shares were sold at an average price of $39.35, for a total transaction of $23,610.00. Following the...

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK) Short Interest Update

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) saw a large decrease in short interest during the month of April. As of April 15th, there was short interest totaling 49,839 shares, a decrease of 15.7% from the March 31st total of 59,096 shares. Based on an average daily...

Peoples Bancorp (NASDAQ:PEBO) Director Purchases $34,510.00 in Stock

Peoples Bancorp Inc. (NASDAQ:PEBO - Get Free Report) Director Dwight Eric Smith acquired 1,000 shares of the stock in a transaction dated Monday, April 27th. The stock was purchased at an average...

Insider Selling: Peoples Bancorp of North Carolina (NASDAQ:PEBK) Director Sells 600 Shares of Stock

Peoples Bancorp of North Carolina, Inc. (NASDAQ:PEBK - Get Free Report) Director James Abernethy sold 600 shares of the firm's stock in a transaction on Thursday, April 23rd. The stock was sold at an...

DA Davidson Forecasts Strong Price Appreciation for Peoples Bancorp (NASDAQ:PEBO) Stock

DA Davidson boosted their price objective on shares of Peoples Bancorp from $37.00 to $38.00 and gave the stock a "buy" rating in a research report on Wednesday...

Peoples Bancorp (NASDAQ:PEBO) Stock Price Expected to Rise, Hovde Group Analyst Says

Hovde Group raised their price objective on Peoples Bancorp from $33.00 to $36.00 and gave the stock a "market perform" rating in a research note on Wednesday...

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Stock Crosses Above 200-Day Moving Average - Here's Why

Peoples Bancorp of North Carolina (NASDAQ:PEBK) Stock Price Passes Above 200-Day Moving Average - Time to Sell...

Peoples Bancorp Inc. (NASDAQ:PEBO) Plans Quarterly Dividend of $0.42

Peoples Bancorp Inc. (NASDAQ:PEBO) announced a quarterly dividend on Monday, April 20th. Investors of record on Monday, May 4th will be paid a dividend of 0.42 per share by the bank on Monday, May 18th. This represents a c) annualized dividend and a dividend yield of 4.9%. The ex-dividend date of...

Peoples Bancorp, Inc. operates as a financial holding company, which engages in banking, investment, insurance, and trust solutions. It offers various demand deposit accounts, savings accounts, money market accounts and certificates of deposit, commercial, consumer, real estate mortgage loans and lines of credit, debit and automated teller machine cards, credit cards for individuals and businesses, merchant credit card transaction processing services, corporate and personal trust services, safe deposit rental facilities, money orders and cashier's checks, life, health, property and casualty insurance products, brokerage services, and custom-tailored fiduciary, employee benefit plans and asset management & administration services. The company was founded in 1980 and is headquartered in Marietta, OH.

Peoples Bancorp, Inc. (Marietta, OH)

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$38.75
Prev Close	$38.79
Open	$38.89
Dividend Yield	5.43%
50-Day Moving Average	$35.34
Beta	0.72
Avg. Volume	283,009.55
PE Ratio	12.44

52-Week High	$39.33
52-Week Low	$27.49
Market Capitalization	$1.39B
EPS (Annual)	$2.99
Price to Book	1.14
Revenue Per Employee	$425,310.18

Feed

News

Sentiment

Earnings

Fundamentals

Info

PEBOPeoples Bancorp, Inc. (Marietta, OH)

Latest PEBO News